Copyright
©The Author(s) 2022.
World J Cardiol. Jul 26, 2022; 14(7): 411-426
Published online Jul 26, 2022. doi: 10.4330/wjc.v14.i7.411
Published online Jul 26, 2022. doi: 10.4330/wjc.v14.i7.411
Table 1 Characteristics of participants at baseline
Serum 25(OH)D concentrations | P value | |||||||||
< 20 ng/mL | 20 to 29 ng/mL | ≥ 30 ng/mL | ||||||||
No. | mean, % | (SE) | No. | mean, % | (SE) | No. | mean, % | (SE) | ||
MetS, % | < 0.001 | |||||||||
No | 2640 | 64.7 | 2230 | 70.8 | 1276 | 79.3 | ||||
Yes | 1394 | 35.3 | 1089 | 29.2 | 465 | 20.7 | ||||
Age, yr | 4034 | 45.8 | (0.6) | 3319 | 44.7 | (0.6) | 1741 | 40.3 | (0.6) | < 0.001 |
Waist circumference, cm | 4034 | 94.2 | (0.4) | 3319 | 92.2 | (0.3) | 1741 | 88.3 | (0.4) | < 0.001 |
Body mass index, kg/m2 | 4033 | 27.8 | (0.2) | 3318 | 26.5 | (0.1) | 1739 | 25.0 | (0.1) | < 0.001 |
Systolic BP, mmHg | 4034 | 123.4 | (0.6) | 3319 | 122.0 | (0.6) | 1741 | 119.0 | (0.6) | <0.001 |
Diastolic BP, mmHg | 4034 | 74.7 | (0.3) | 3317 | 74.1 | (0.3) | 1741 | 72.9 | (0.4) | < 0.001 |
Triglycerides, mg/dL | 4034 | 138.9 | (4.1) | 3319 | 136.4 | (2.6) | 1741 | 126.5 | (3.8) | < 0.001 |
HDL-C, mg/dL | 4034 | 51.0 | (0.5) | 3319 | 49.3 | (0.4) | 1741 | 51.5 | (0.6) | < 0.001 |
Glucose, mg/dL | 4034 | 100.7 | (0.7) | 3319 | 98.4 | (0.5) | 1741 | 94.7 | (0.4) | < 0.001 |
Categorical variable, % | ||||||||||
Sex, male, % | 1561 | 38.3 | 178 | 51.9 | 975 | 55.4 | < 0.001 | |||
Race/ethnicity, % | < 0.001 | |||||||||
NHW | 894 | 55.1 | 1557 | 79.7 | 1213 | 92.0 | ||||
NHB | 1788 | 25.8 | 575 | 6.0 | 139 | 1.9 | ||||
Others | 1352 | 19.1 | 1187 | 14.3 | 389 | 6.1 | ||||
Region | < 0.001 | |||||||||
Northeast | 490 | 15.8 | 429 | 20.6 | 303 | 26.7 | ||||
Midwest | 651 | 18.9 | 709 | 24.5 | 434 | 28.1 | ||||
South | 1933 | 40.3 | 1299 | 33.2 | 685 | 29.1 | ||||
West | 960 | 25.0 | 882 | 21.6 | 319 | 16.1 | ||||
Education level | 0.001 | |||||||||
< High school | 930 | 13.1 | 818 | 11.8 | 355 | 8.2 | ||||
High school | 1971 | 49.2 | 1532 | 45.8 | 788 | 46.1 | ||||
> High school | 1113 | 37.7 | 949 | 42.4 | 592 | 45.6 | ||||
Smoking | 0.07 | |||||||||
Never | 2562 | 62.1 | 2230 | 63.9 | 1130 | 62.5 | ||||
Former | 193 | 5.5 | 191 | 6.0 | 105 | 4.0 | ||||
Current | 1279 | 32.4 | 898 | 30.2 | 506 | 33.5 | ||||
Alcohol consumption, yes | 1704 | 44.8 | 1592 | 55.9 | 910 | 63.7 | < 0.001 | |||
Exercise, yes | 0.13 | |||||||||
More activity | 559 | 14.1 | 475 | 16.3 | 287 | 18.4 | ||||
About the same | 2433 | 58.3 | 1998 | 56.2 | 1005 | 52.7 | ||||
Less activity | 1040 | 27.6 | 841 | 27.5 | 445 | 28.9 | ||||
Health conditions | ||||||||||
Hypertension, yes | 1489 | 36.5 | 1129 | 29.6 | 565 | 25.5 | < 0.001 | |||
Diabetes mellitus | 465 | 9.3 | 312 | 6.7 | 105 | 3.3 | < 0.001 | |||
CVD | 278 | 6.3 | 252 | 5.3 | 124 | 3.4 | 0.001 |
Table 2 Age-sex-adjusted mortality from heart disease, cerebrovascular disease, cardiovascular disease, and all-cause mortality
Observed number | Weighted mortalityrate per 10000 PY | P value | |||
No. at risk | Case | Rate | (95%CI) | ||
Heart Disease | |||||
25(OH)D, ng/mL | |||||
≥ 30 | 1741 | 130 | 11.7 | (8.2-16.6) | Ref. |
20-29 | 3319 | 272 | 13.2 | (10.3-16.9) | 0.43 |
< 20 | 4034 | 292 | 17.4 | (13.1-23.0) | 0.012 |
CBVD | |||||
25(OH)D, ng/mL | |||||
≥ 30 | 1741 | 34 | 3.6 | (2.0-6.6) | Ref. |
20-29 | 3319 | 83 | 3.6 | (2.5-5.1) | 0.97 |
< 20 | 4034 | 88 | 4.5 | (2.5-7.9) | 0.53 |
CVD | |||||
25(OH)D, ng/mL | |||||
≥ 30 | 1741 | 164 | 15.3 | (11.4-20.5) | Ref. |
20-29 | 3319 | 355 | 16.6 | (13.3-20.7) | 0.56 |
< 20 | 4034 | 382 | 21.3 | (16.6-27.3) | 0.023 |
All-cause | |||||
25(OH)D, ng/mL | |||||
≥ 30 | 1741 | 545 | 75.9 | (64.9-88.8) | Ref. |
20-29 | 3319 | 1141 | 87.5 | (79.4-96.3) | 0.066 |
< 20 | 4034 | 1290 | 103.9 | (93.2-115.8) | < 0.001 |
MetS status | |||||
Heart Disease | |||||
MetS, no | 6146 | 327 | 12.5 | (9.7-16.2) | Ref. |
MetS, yes | 2948 | 369 | 16.7 | (12.9-21.7) | 0.002 |
CBVD | |||||
MetS, no | 6146 | 97 | 3.2 | (2.2-4.7) | Ref. |
MetS, yes | 2948 | 108 | 5.1 | (2.9-8.9) | 0.059 |
CVD | |||||
MetS, no | 6146 | 424 | 15.9 | (13.0-19.5) | Ref. |
MetS, yes | 2948 | 477 | 22.0 | (16.9-28.6) | < 0.001 |
All-cause | |||||
MetS, no | 6146 | 1490 | 82.5 | (75.3-90.5) | Ref. |
MetS, yes | 2948 | 1486 | 102.4 | (91.0-115.3) | < 0.001 |
Table 3 Hazard ratios of serum 25 hydroxyvitamin D concentration and metabolic syndrome for heart disease, cerebrovascular disease, cardiovascular disease, and all-cause mortality
Model 1 | Model 2 | |||||
HR | (95%CI) | P value | HR | (95%CI) | P value | |
Ref to 25(OH)D ≥ 30 ng/dL | ||||||
25(OH)D for HD | ||||||
20-29 | 1.13 | (0.82-1.55) | 0.45 | 1.13 | (0.83-1.52) | 0.43 |
< 20 | 1.54 | (1.14-2.08) | 0.005 | 1.43 | (1.07-1.91) | 0.017 |
25(OH)D for CBVD | ||||||
20-29 | 0.97 | (0.61-1.53) | 0.88 | 0.98 | (0.62-1.56) | 0.94 |
< 20 | 1.15 | (0.58-2.26) | 0.69 | 1.14 | (0.58-2.25) | 0.69 |
25(OH)D for CVD | ||||||
20-29 | 1.09 | (0.82-1.46) | 0.54 | 1.10 | (0.82-1.46) | 0.52 |
< 20 | 1.44 | (1.09-1.91) | 0.011 | 1.36 | (1.04-1.78) | 0.028 |
25(OH)D for all-cause mortality | ||||||
20-29 | 1.16 | (0.99-1.35) | 0.06 | 1.16 | (0.99-1.36) | 0.07 |
< 20 | 1.38 | (1.16-1.64) | 0.001 | 1.32 | (1.10-1.58) | 0.004 |
Ref to Non-MetS | ||||||
MetS for HD | 1.31 | (1.09-1.58) | 0.005 | 1.22 | (1.00-1.49) | 0.053 |
MetS for CBVD | 1.58 | (0.94-2.66) | 0.083 | 1.60 | (0.96-2.65) | 0.069 |
MetS for CVD | 1.37 | (1.12-1.66) | 0.002 | 1.29 | (1.05-1.59) | 0.017 |
MetS for all-cause mortality | 1.22 | (1.08-1.37) | 0.002 | 1.20 | (1.05-1.36) | 0.008 |
Interaction of | ||||||
25(OH)D x MetS on | ||||||
HD | 0.91 | (0.72-1.17) | 0.46 | 0.91 | (0.72-1.15) | 0.41 |
CBVD | 0.80 | (0.39-1.66) | 0.54 | 0.79 | (0.38-1.62) | 0.50 |
CVD | 0.89 | (0.71-1.12) | 0.31 | 0.88 | (0.70-1.11) | 0.28 |
All-cause | 0.98 | (0.84-1.14) | 0.78 | 0.96 | (0.82-1.13) | 0.63 |
Table 4 Top 10 important predicators for classifying serum 25 Hydroxyvitamin D levels in the total and sex-specific samples
S1: In both sex | S2: In males | S3: In females | S4: In both sex | S5: In males | S6: In females | |||||||
≥ 20 vs < 20 | ≥ 20 vs < 20 | ≥ 20 vs < 20 | ≥ 30 vs < 30 | ≥ 30 vs < 30 | ≥ 30 vs < 30 | |||||||
Rank | Predictor | MDG | Predictor | MDG | Predictor | MDG | Predictor | MDG | Predictor | MDG | Predictor | MDG |
1 | Race | 519.5 | Race | 229.7 | Race | 267.7 | Race | 200.0 | Race | 95.2 | Race | 103.9 |
2 | Folate | 90.4 | RBP | 19.6 | Folate | 101.3 | Age | 97.5 | WC | 34.0 | Age | 79.4 |
3 | Sex | 57.3 | Age | 14.8 | Age | 77.5 | Folate | 65.1 | BMI | 29.0 | GFR | 50.6 |
4 | Region | 34.3 | Glucose | 14.2 | GFR | 73.7 | GFR | 54.8 | AGE | 28.9 | Folate | 49.6 |
5 | RBP | 34.0 | GFR | 13.1 | RBP | 50.7 | BMI | 48.8 | Region | 24.8 | RBP | 34.1 |
6 | Poverty | 33.3 | Poverty | 12.8 | Poverty | 50.1 | WC | 42.2 | GFR | 22.7 | WC | 32.0 |
7 | Edu | 30.3 | Region | 11.9 | WC | 22.9 | Poverty | 41.4 | Insulin | 18.9 | SBP | 26.9 |
8 | GFR | 29.6 | WC | 11.1 | VEP | 21.1 | RBP | 39.8 | C1P | 18.8 | BMI | 23.2 |
9 | UAP | 27.7 | Folate | 10.9 | SBP | 16.1 | Glucose | 22.0 | RBP | 18.6 | VEP | 22.0 |
10 | Alcoh | 21.6 | Edu | 9.8 | A1C | 14.6 | DairyHEI | 20.8 | Poverty | 17.4 | Poverty | 18.8 |
Accuracy,% | 71.1 | 70.8 | 68.0 | 81.5 | 79.3 | 81.8 | ||||||
Precision, % | 68.4 | 68.2 | 68.2 | 83.0 | 82.4 | 85.6 | ||||||
Recall,% | 63.0 | 47.5 | 68.5 | 97.0 | 93.5 | 94.0 | ||||||
F1 score, % | 65.6 | 56.0 | 68.3 | 89.5 | 87.6 | 89.6 |
- Citation: Liu L, Cui S, Volpe SL, May NS, Sukumar D, DiMaria-Ghalili RA, Eisen HJ. Vitamin d deficiency and metabolic syndrome: The joint effect on cardiovascular and all-cause mortality in the United States adults . World J Cardiol 2022; 14(7): 411-426
- URL: https://www.wjgnet.com/1949-8462/full/v14/i7/411.htm
- DOI: https://dx.doi.org/10.4330/wjc.v14.i7.411